Tozaro is a biotechnology company that develops synthetic affinity reagents for cell and gene therapy.
Tozaro has raised $8.2M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in February 2026.
Tozaro's investors include Bill & Melinda Gates Foundation, Mercia Ventures, Calculus Capital.
Tozaro is headquartered in Bedford, United Kingdom.
Tozaro is a biotechnology company that develops synthetic affinity reagents for cell and gene therapy.
Tozaro is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Tozaro — Funding & Investors." VCBacked, February 16, 2026, https://www.vcbacked.co/company/tozaro. Accessed September 30, 2026.
VCBacked. (2026). Tozaro — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/tozaro
{{cite web |title=Tozaro — Funding & Investors |url=https://www.vcbacked.co/company/tozaro |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated